The Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its tough gel adhesive technology has been licensed by UF Innovate | Sid Martin Biotech alum Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.
Through a licensing agreement coordinated by Harvard’s Office of Technology Development (OTD), Amend Surgical has been granted exclusive rights to initiate the development of the technology for applications within the field of oral surgery. The company aims to redefine the current standard of care, which today often requires painful and irritating sutures to be placed by the clinician in the tight, difficult-to-access oral cavity.
“Both our engineering and clinical teams were involved in the evaluation of this important technology, and we are eager to begin commercialization. We envision that the tough adhesive could provide clinicians both a wound barrier and an effective means to protect bone grafts in a single, easy-to-apply product, and could potentially eliminate the need for sutures used in conjunction with most dental barriers,” said Robby Lane, co-founder and CEO of Amend Surgical.Learn more about Harvard’s Tough Gel Technology Licensed to Amend Surgical for Oral Surgery Applications.